BioNexus Gene Lab Corp.
BGLC
$5.38
-$0.04-0.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.92% | -17.86% | 5.81% | -23.58% | -7.17% |
| Total Receivables | 19.06% | 6.21% | 9.99% | 8.41% | 40.10% |
| Inventory | 3.10% | -15.09% | -0.04% | 34.47% | -4.09% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.49% | -11.95% | 5.55% | -10.24% | -0.79% |
|
|
|||||
| Total Current Assets | -2.49% | -11.95% | 5.55% | -10.24% | -0.79% |
| Net Property, Plant & Equipment | 4.00% | -0.81% | -11.38% | 23.41% | -0.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -0.62% | -9.14% | -5.11% | -1.30% | -0.20% |
|
|
|||||
| Total Accounts Payable | 15.63% | -21.33% | 45.51% | 8.20% | -33.19% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -3.07% | -5.23% | -7.53% | -91.37% | 437.41% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.90% | 2.76% | 5.39% | -9.40% | 63.69% |
| Total Finance Division Other Current Liabilities | 3.07% | -18.63% | 20.63% | 79.18% | -18.12% |
| Total Other Current Liabilities | 3.07% | -18.63% | 20.63% | 79.18% | -18.12% |
| Total Current Liabilities | 12.65% | -20.03% | 37.91% | 1.11% | -18.47% |
|
|
|||||
| Total Current Liabilities | 12.65% | -20.03% | 37.91% | 1.11% | -18.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -3.07% | -5.23% | -7.53% | -91.37% | 437.41% |
| Capital Leases | -4.46% | -7.39% | -10.48% | -2.35% | 105.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 14.29% | 0.00% |
| Total Liabilities | 11.17% | -19.08% | 31.37% | 0.81% | -12.29% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.82% | 0.00% |
| Retained Earnings | -15.16% | -18.11% | -11.26% | -76.93% | 10.22% |
| Treasury Stock & Other | 6.68% | 1.30% | -14.79% | 17.75% | 0.04% |
| Total Common Equity | -3.21% | -6.62% | -11.35% | -1.65% | 2.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.21% | -6.62% | -11.35% | -1.65% | 2.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.21% | -6.62% | -11.35% | -1.65% | 2.16% |
|
|
|||||